Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10358 |
| Vaccine Name | Seqirus QIV |
| Disease Name | Influenza (flu) |
| Disease Classification | Respiratory |
| Virus Name | Influenza virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Phase 3 |
| Manufacturer | Seqirus |
| Year of Manufacturing | 2019 |
| Manufacturing Country | USA |
| Age | 6 months - 59 months |
| Dosage | 1- 2 doses depending on volume and age |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Four recommended influenza strains for the Northern Hemisphere 2016/2017 influenza season |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT02914275 |
| Reference Link | https://www.clinicaltrials.gov/ct2/show/NCT02914275 |
| Additional Links | NA |